AstraZeneca Pharma India Limited has been assigned an Environmental, Social, and Governance (ESG) rating of 70 by NSE Sustainability Ratings & Analytics Limited. This rating is based on publicly available information covering the Financial Year 2024-25. The company clarified that this assessment was conducted independently by NSE Sustainability and was not an engagement commissioned by AstraZeneca Pharma India Limited.
ESG Rating Announcement for FY 2024-25
AstraZeneca Pharma India Limited today disclosed its latest Environmental, Social, and Governance (ESG) assessment score. The company was informed on February 17, 2026, that it has been assigned an ESG rating of 70.
This rating pertains specifically to the performance during the Financial Year ending March 31, 2025 (FY 2024-25). The evaluation was based exclusively on publicly available information regarding the Company’s operations and sustainability performance during that period.
Independence of the Assessment
It is important to note that AstraZeneca Pharma India Limited has not engaged NSE Sustainability for the purpose of obtaining this ESG rating. The report and subsequent rating were prepared and assigned independently by NSE Sustainability, relying solely on public disclosures.
This disclosure is made in accordance with the applicable regulatory requirements concerning the dissemination of material information related to ESG performance metrics.
Source: BSE
